Bakuchiol ferulate mimics retinol gene expression with superior stability and tolerance

Bakuchiol ferulate, a newly synthesized molecular hybrid, mimics the gene expression profile of retinol while offering significantly higher stability and skin tolerance. In a 90-day stability study published on July 20, 2026, the hybrid compound retained over 86% of its concentration under light exposure and resisted degradation at 48 degrees Celsius, while traditional retinol retention plummeted to 6% and 8% under the same conditions. For patients who struggle with retinoid dermatitis, the compound showed a photoirritation factor of 1.14 compared to retinol's 5.64. Furthermore, in a 14-day patch test, formulations of the hybrid up to 1.0% remained completely nonirritating, whereas 0.3% retinol caused mild irritation. While lab testing on human dermal fibroblasts showed a high transcriptomic similarity of 0.89 between the two, the hybrid lacked retinol's typical inflammatory signatures. Investigators note that transcriptomic similarity does not automatically guarantee equivalent clinical efficacy, but this molecule offers a highly stable, low-irritation option to watch for future medical-grade topical formulations.

Source: Dermatology Times, https://www.dermatologytimes.com/view/beyond-retinol-evaluating-the-stability-safety-and-gene-expression-profile-of-bakuchiol-ferulate